XOMA Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US98419J2069
USD
29.77
1.06 (3.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Rigel Pharmaceuticals, Inc.
Verrica Pharmaceuticals, Inc.
XOMA Corp.
Emergent BioSolutions, Inc.
Zomedica Corp.
Fusion Pharmaceuticals, Inc.
Gossamer Bio, Inc.
Omeros Corp.
Merrimack Pharmaceuticals, Inc.
Sagimet Biosciences, Inc.
Tenaya Therapeutics, Inc.

Why is XOMA Corp. ?

1
With a growth in Net Sales of 47.12%, the company declared Very Positive results in Sep 25
  • OPERATING CASH FLOW(Y) Highest at USD 5.39 MM
  • ROCE(HY) Highest at 16.22%
  • NET SALES(9M) Higher at USD 38.39 MM
2
With ROE of -7.51%, it has a attractive valuation with a 3.05 Price to Book Value
  • Over the past year, while the stock has generated a return of 37.43%, its profits have fallen by -487.7%
3
High Institutional Holdings at 72.35%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 1.27% over the previous quarter.
4
Market Beating Performance
  • The stock has generated a return of 37.43% in the last 1 year, much higher than market (S&P 500) returns of 14.90%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to XOMA Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is XOMA Corp. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
XOMA Corp.
42.58%
0.41
56.51%
S&P 500
16.12%
0.77
19.29%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
84.06%
EBIT Growth (5y)
-8.58%
EBIT to Interest (avg)
0.06
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.11
Tax Ratio
66.43%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
71.08%
ROCE (avg)
16.13%
ROE (avg)
3.99%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.05
EV to EBIT
-16.57
EV to EBITDA
-18.59
EV to Capital Employed
2.74
EV to Sales
7.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-16.55%
ROE (Latest)
-7.51%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 5.39 MM

ROCE(HY)

Highest at 16.22%

NET SALES(9M)

Higher at USD 38.39 MM

PRE-TAX PROFIT(Q)

Highest at USD 18.04 MM

NET PROFIT(Q)

Highest at USD 14.28 MM

EPS(Q)

Highest at USD 0.7

-5What is not working for the Company
NET SALES(Q)

At USD 9.35 MM has Fallen at -16.79%

RAW MATERIAL COST(Y)

Grown by 9.47% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 36.97 %

Here's what is working for XOMA Corp.

Pre-Tax Profit
At USD 18.04 MM has Grown at 348.2%
over average net sales of the previous four periods of USD -7.27 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 14.28 MM has Grown at 322.05%
over average net sales of the previous four periods of USD -6.43 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Operating Cash Flow
Highest at USD 5.39 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Pre-Tax Profit
Highest at USD 18.04 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 14.28 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 0.7
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for XOMA Corp.

Net Sales
At USD 9.35 MM has Fallen at -16.79%
over average net sales of the previous four periods of USD 11.24 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (USD MM)

Debt-Equity Ratio
Highest at 36.97 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 9.47% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income
Highest at USD 1.61 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income